Home
About
Contact
DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Your search for
Hematology | All Regions
returned
25
studies.
Enrollment complete
Who can join
A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A RANDOMIZED PHASE III STUDY OF BENDAMUSTINE PLUS RITUXIMAB VERSUS IBRUTINIB PLUS RITUXIMAB VERSUS IBRUTINIB ALONE IN UNTREATED OLDER PATIENTS (= 65 YEARS OF AGE) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, not yet recruiting
Who can join
A Phase 2 Study of Revumenib (SNDX-5613) in Combination With Chemotherapy for Patients With Relapsed or Refractory KMT2A-Rearranged Infant Leukemia
Keywords:
Leukemia; Leukemia; Myeloid; Leukemia; Myeloid; Acute; Precursor Cell…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Keywords:
Lymphoma; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase I/II, Open-Label, Single-Arm, Two-Part Trial to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination With Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Keywords:
Relapsed; Refractory; B-NHL;Hematology;Oncology (Pediatrics);
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
Keywords:
Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia; Lymphoid;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma
Keywords:
Oncology (Adult);Allergy and Immunology;Hematology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Keywords:
Oncology (Adult);Allergy and Immunology;Hematology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
Enrollment complete
Who can join
VS-6063 (defactinib) in Patients with Tumors with NF2 Loss (MATCH Substudy)
Keywords:
Oncology (Adult);Hematology;
Study Type:
INTERVENTIONAL |
Region:
Colorado
1
2
3